Skip to main content
OpenTrials

Clinical trial condition

BCCs in Gorlin Syndrome Patients

Explore clinical trials studying BCCs in Gorlin Syndrome Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

BCCs in Gorlin Syndrome Patients trial results

Completed

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

NCT04893486

Conditions
Abnormalities, Multiple, BCCs in Gorlin Syndrome Patients, Basal Cell Nevus Syndrome, +19 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Burke Pharmaceuticals Research Hot Springs, Arkansas, United States
  • Stanford Univeristy Palo Alto, California, United States
  • Park Avenue Dermatology Orange Park, Florida, United States
View all 16 locations
View Trial Details

Related conditions